Sclerostin shown to be key protein for cardiovascular health in patients with type 2 diabetes
A study involving the University of Granada (UGR) and published in the journal Cardiovascular Diabetology has shown that sclerostin plays a protective role against the development of atherosclerosis in patients with type 2 diabetes